| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.0091 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |